PNPLA2 Antikörper (AA 265-504)
Kurzübersicht für PNPLA2 Antikörper (AA 265-504) (ABIN6145857)
Target
Alle PNPLA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 265-504
-
Sequenz
- PPARPHGPED KDQAVESAQA EDYSQLPGED HILEHLPARL NEALLEACVE PTDLLTTLSN MLPVRLATAM MVPYTLPLES ALSFTIRLLE WLPDVPEDIR WMKEQTGSIC QYLVMRAKRK LGRHLPSRLP EQVELRRVQS LPSVPLSCAA YREALPGWMR NNLSLGDALA KWEECQRQLL LGLFCTNVAF PPEALRMRAP ADPAPAPADP ASPQHQLAGP APLLSTPAPE ARPVIGALGL
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 265-504 of human PNPLA2 (NP_065109.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000,IF,1:50 - 1:200
-
Kommentare
-
HIGH QUALITY
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- PNPLA2 (Patatin-Like phospholipase Domain Containing 2 (PNPLA2))
-
Andere Bezeichnung
- PNPLA2
-
Hintergrund
- This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy.,PNPLA2,1110001C14Rik,ATGL,FP17548,PEDF-R,TTS-2.2,TTS2,iPLA2zeta,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Lipases,Endocrine and metabolic diseases,Metabolic disorders,Obesity,Cardiovascular,Lipids,PNPLA2
-
Molekulargewicht
- 19 kDa/55 kDa
-
Gen-ID
- 57104
-
UniProt
- Q96AD5
Target
-